Youarereviewinaapatientintheoutoatientdepartmentwhohasrecentvbeendiaanosed withtuberculosis
andhasbeen startedoncombinationtherapv with isoniazd.rffamoicin. ovrazinamideandethambutoLYour
consutantasksyoutoarranaeforteststodetermineacetvlator status:
Which adverseeffects would beexpectedtobe moreuikeuytooccurifthepatient wasfoundtobea
sLow acetyLator?
CraniaLnerve palsv
Hepatitis
Peripheralneuropathy
RenaLtoxicity
Visualdisturbances
@1MINNDOCRINE
